Home / Going-concern warnings / Regen BioPharma Inc
Filed 2025-05-13 路 Form 10-K 路 Accession 0001641172-25-009968 nano
Price before filing: $0.064 (2025-05-12 close, split/dividend-adjusted)
Market cap at flag: $1.4M (2025-05-13) 路 Latest: $61,556 (2026-10-16)
| Window | RGBP | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -6.2% | +3.6% | -9.8% | 2025-06-12 |
| 90 days | -37.6% | +9.4% | -47.1% | 2025-08-11 |
| 180 days | -82.8% | +17.6% | -100.4% | 2025-11-10 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As discussed in Note 2 to the consolidated financial statements, the Company's significant operating losses raise substantial doubt about its ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Going-concern opinion issued by: BCRG Group
Source: independent auditor report in Form 10-K (period 2024-09-30)
Why this score: in auditor's report; also within 90 days: Auditor change, Non-reliance / restatement
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.